LLY

1,108.92

+3.86%↑

JNJ

206.8

+0.38%↑

ABBV

231.86

+1.03%↑

UNH

326.26

+2.45%↑

AZN

93.26

+1.86%↑

LLY

1,108.92

+3.86%↑

JNJ

206.8

+0.38%↑

ABBV

231.86

+1.03%↑

UNH

326.26

+2.45%↑

AZN

93.26

+1.86%↑

LLY

1,108.92

+3.86%↑

JNJ

206.8

+0.38%↑

ABBV

231.86

+1.03%↑

UNH

326.26

+2.45%↑

AZN

93.26

+1.86%↑

LLY

1,108.92

+3.86%↑

JNJ

206.8

+0.38%↑

ABBV

231.86

+1.03%↑

UNH

326.26

+2.45%↑

AZN

93.26

+1.86%↑

LLY

1,108.92

+3.86%↑

JNJ

206.8

+0.38%↑

ABBV

231.86

+1.03%↑

UNH

326.26

+2.45%↑

AZN

93.26

+1.86%↑

Начало・Списък с акции・Lisata Therapeutics

L
Lisata Therapeutics

Затворен

1.97 2.07

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.8399999999999999

Максимум

2.02

Ключови измерители
By Trading Economics
Служители	26

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-4.5M 16M
Предишно отваряне	-0.1
Предишно затваряне	1.97

Lisata Therapeutics Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

25.11.2025 г., 16:56 ч. UTC

Печалби

Значими двигатели на пазара

Alimentation Couche-Tard Shares Rise as 2Q Same-Store Sales Support Profit Growth

25.11.2025 г., 23:47 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

25.11.2025 г., 23:47 ч. UTC

Пазарно говорене

Nikkei May Rise After Stock Gains on Wall Street -- Market Talk

25.11.2025 г., 22:39 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

25.11.2025 г., 22:39 ч. UTC

Пазарно говорене

Vault Accelerates Exposure to Spot Gold Prices by Six Months -- Market Talk

25.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

25.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

25.11.2025 г., 21:38 ч. UTC

Печалби

HP Inc. Has a Memory Problem. Financial Forecasts Take a Hit. -- Barrons.com

25.11.2025 г., 21:31 ч. UTC

Пазарно говорене

F&P Healthcare's Share Price Jumps on Profit Guidance Upgrade -- Market Talk

25.11.2025 г., 21:27 ч. UTC

Печалби

These Stocks Moved the Most Today: Nvidia, AMD, Alphabet, Abercrombie, Kohl's, Novo Nordisk, Symbotic, and More -- Barrons.com

25.11.2025 г., 21:20 ч. UTC

Печалби

HP Inc. Has a Memory Problem. Financial Forecasts Take a Hit. -- Barrons.com

25.11.2025 г., 21:18 ч. UTC

Печалби

NIO Stock Drops as EV Maker Posts Narrower Loss -- Barrons.com

25.11.2025 г., 21:15 ч. UTC

Печалби

HP Inc. Has a Memory Problem. Financial Forecasts Take a Hit. -- Barrons.com

25.11.2025 г., 20:16 ч. UTC

Пазарно говорене

U.S. Natural Gas Falls as December Contract Expires -- Market Talk

25.11.2025 г., 18:42 ч. UTC

Пазарно говорене

USDA Backs Mexican Retail Expo to Raise Agricultural Exports -- Market Talk

25.11.2025 г., 18:25 ч. UTC

Придобивния, сливания и поглъщания

S&P Global Completes $1.8 Billion Acquisition Of With Intelligence, Strengthening Its Position As A Leader In Private Markets Data & Analytics >SPGI

25.11.2025 г., 17:30 ч. UTC

Пазарно говорене

Mexico Posts Record Foreign Direct Investment for Jan-Sep -- Market Talk

25.11.2025 г., 17:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

25.11.2025 г., 17:20 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

25.11.2025 г., 16:33 ч. UTC

Придобивния, сливания и поглъщания

Eni: Financial Details Weren't Disclosed

25.11.2025 г., 16:33 ч. UTC

Придобивния, сливания и поглъщания

Eni: Block OFF-5 Covers an Area of About 17,000 Km Sq. in Water Depths

25.11.2025 г., 16:32 ч. UTC

Придобивния, сливания и поглъщания

Eni: Agreement to Become Effective After Approval of Uruguayan Authorities

25.11.2025 г., 16:31 ч. UTC

Придобивния, сливания и поглъщания

Eni: Acquisition Is for a 50% Share, Operatorship in Exploration Block OFF-5

25.11.2025 г., 16:30 ч. UTC

Придобивния, сливания и поглъщания

Eni Acquires From YPF Shares in the Exploration Block OFF-5 Offshore Uruguay

25.11.2025 г., 16:23 ч. UTC

Печалби

This Robotics Stock Soars 40% on Earnings. Here's Why. -- Barrons.com

25.11.2025 г., 16:12 ч. UTC

Пазарно говорене

Euro Expected to Rise to $1.25 in 2026: Deutsche Bank -- Market Talk

25.11.2025 г., 16:11 ч. UTC

Пазарно говорене

Dollar Could Take One Final Leg Lower in Early 2026 -- Market Talk

25.11.2025 г., 16:10 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

25.11.2025 г., 16:10 ч. UTC

Пазарно говорене

Sterling Could Briefly Rise After Budget -- Market Talk

25.11.2025 г., 16:10 ч. UTC

Пазарно говорене

Oil Extends Losses on Ukraine-Russia Peace Deal Hopes -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Lisata Therapeutics Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Lisata Therapeutics през последните 3 месеца.

Финанси

Относно Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.